Novavax vaccine is highly protective against COVID-19 in Phase 3 results
June 17, 2021
UT Health San Antonio collaborated with University Health as part of the international COVID-19 Prevention Network and enrolled 176 Novavax clinical trial participants in San Antonio for the Phase 3 study, which is called PREVENT-19.